AURX
Price:
$2.26
Market Cap:
$108.66M
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
Industry
Biotechnology
IPO Date
2017-10-24
Stock Exchange
OTC
Ticker
AURX
According to Nuo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.16. This represents a change of 18.10% compared to the average of 0.99 of the last 4 quarters.
The mean historical Current Ratio of Nuo Therapeutics, Inc. over the last ten years is 1.38. The current 1.16 Current Ratio has changed 8.35% with respect to the historical average. Over the past ten years (40 quarters), AURX's Current Ratio was at its highest in in the June 2022 quarter at 8.33. The Current Ratio was at its lowest in in the September 2020 quarter at 0.
Average
1.38
Median
1.04
Minimum
0.07
Maximum
4.39
Discovering the peaks and valleys of Nuo Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.73%
Maximum Annual Current Ratio = 4.39
Minimum Annual Increase = -97.19%
Minimum Annual Current Ratio = 0.07
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.45 | -37.23% |
| 2023 | 2.32 | -47.18% |
| 2022 | 4.39 | 1.87% |
| 2021 | 0.22 | -2.58% |
| 2020 | 0.23 | -3.00% |
| 2019 | 0.24 | -71.21% |
| 2018 | 0.82 | -35.21% |
| 2017 | 1.27 | -54.33% |
| 2016 | 2.77 | 3.73% |
| 2015 | 0.07 | -97.19% |
The current Current Ratio of Nuo Therapeutics, Inc. (AURX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.72
5-year avg
1.72
10-year avg
1.38
Nuo Therapeutics, Inc.’s Current Ratio is greater than Kintor Pharmaceutical Limited (0.44), less than Paradigm Biopharmaceuticals Limited (7.46), less than Poolbeg Pharma PLC (24.94), greater than Hofseth BioCare ASA (0.96), less than Satellos Bioscience Inc. (11.13), less than VitaSpring Biomedical Co. Ltd. (1.97), less than Imugene Limited (1.88), greater than Green Growth Brands Inc. (0.29), greater than AVITA Medical, Inc. (0.58), less than Starpharma Holdings Limited (4.32),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.44 | $94.90M | |
| 7.46 | $109.88M | |
| 24.94 | $29.63M | |
| 0.96 | $66.68M | |
| 11.13 | $87.00M | |
| 1.97 | $207.03M | |
| 1.88 | $57.72M | |
| 0.29 | $2.06K | |
| 0.58 | $95.66M | |
| 4.32 | $99.94M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nuo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Nuo Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Nuo Therapeutics, Inc. (AURX)?
What is the highest Current Ratio for Nuo Therapeutics, Inc. (AURX)?
What is the 3-year average Current Ratio for Nuo Therapeutics, Inc. (AURX)?
What is the 5-year average Current Ratio for Nuo Therapeutics, Inc. (AURX)?
How does the current Current Ratio for Nuo Therapeutics, Inc. (AURX) compare to its historical average?